This document discusses anemia in pregnancy, defining it as a hemoglobin level below 11g/dL in the first trimester, 10.5g/dL in the second trimester, and 11g/dL in the third trimester. It classifies anemias based on their cause into reduced red blood cell production, increased red blood cell destruction, or increased blood loss. The most common anemias in pregnancy are nutritional deficiencies of iron, folic acid, and vitamin B12, as well as hemoglobinopathies like sickle cell disease and thalassemias. Prevention is key and involves health education, administration of hematinics and antimalarial prophylaxis, and insecticide treated nets. Treatment
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, life-threatening disease of the blood characterized by destruction of red Blood cells by the complement system, a part of the body's innate immune system.
The disease is characterized by destruction of red blood cells (hemolytic anemia), blood clots (thrombosis), and impaired bone marrow function (not making enough of the three blood components). It has been known to result from somatic mutations in the PIGA gene, which encodes phosphatidylinositol glycan class A (PIGA).Most treatments for PNH aim to reduce symptoms and prevent complications.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, life-threatening disease of the blood characterized by destruction of red Blood cells by the complement system, a part of the body's innate immune system.
The disease is characterized by destruction of red blood cells (hemolytic anemia), blood clots (thrombosis), and impaired bone marrow function (not making enough of the three blood components). It has been known to result from somatic mutations in the PIGA gene, which encodes phosphatidylinositol glycan class A (PIGA).Most treatments for PNH aim to reduce symptoms and prevent complications.
Diabetes means to pass something abnormal with urine and mellitus means honey and this is the exact translation of term Madhumeh which was first mentioned by Sushrut in 200 AD. Term Diabetes Mellitus is invented in last century only so it is evident that Ayurvedic Seers were already knowing about all the details about disease. Sushrut despite dealing with Surgery wrote a full chapter on Madhumeh viz Diabetes Mellitus in Nidan Sthan and then in Chikitsa Sthan. Sushrut emphasised on Diabetes Mellitus may be coz he was counteracting the complications during surgeries.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
Diabetes means to pass something abnormal with urine and mellitus means honey and this is the exact translation of term Madhumeh which was first mentioned by Sushrut in 200 AD. Term Diabetes Mellitus is invented in last century only so it is evident that Ayurvedic Seers were already knowing about all the details about disease. Sushrut despite dealing with Surgery wrote a full chapter on Madhumeh viz Diabetes Mellitus in Nidan Sthan and then in Chikitsa Sthan. Sushrut emphasised on Diabetes Mellitus may be coz he was counteracting the complications during surgeries.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
3. INTRODUCTION
• COMMONEST HEMATOLOGICAL DISORDER IN PREGNANCY
• HIGH INCIDENCE IN UNDERDEVELOPED COUNTRIES
• • RESPONSIBLE FOR SIGNIFICANT HIGH MATERNAL MORBIDITY AND MORTALITY
AND INCREASED FETAL MORTALITY RATE WORLDWIDE
3
4. DEFINITION
• DEFINED BY THE VALUE OF HAEMOGLOBIN- WHEN THE BLOOD HAEMOGLOBIN
VALUE IS LESS THAN THE FIFTH PERCENTILE OF THE DISTRIBUTION OF HB IN A
HEALTHY REFERENCE POPULATION BASED ON THE STAGE OF PREGNANCY
• WHO DEFINES IT AS HAEMOGLOBIN CONCENTRATION IN THE PERIPHERAL
BLOOD IS <11G/DL(33%) IN THE FIRST TRIMESTER, 10.5G/DL(32%) IN THE
SECOND TRIMESTER AND 11G/DL(33%) IN THIRD TRIMESTER
• IN THE TROPICS, HB <10G/DL (OR PCV OF LESS THAN 30%) IS ACCEPTABLE
4
5. CLASSIFICATION
1. REDUCED RBC
PRODUCTION
2. INCREASED RBC
DESTRUCTION
3. INCREASED BLOOD LOSS
A) NUTRITIONAL ANEMIA :
IRON DEFICIENCY, FOLIC
ACID DEFICIENCY, VITAMIN
B12 DEFICIENCY
A) INHERITED HEMOLYTIC
ANEMIAS- SICKLE CELL
ANEMIA THALASSAEMIA
MAJOR, HEREDITARY
SPHEROCYTOSIS
A) ACUTE BLOOD LOSS-
ABORTION, ECTOPIC
PREGNANCY, APH, RETAINED
PLACENTA WITH
PPH,RUPTURED UTERUS
B) SYSTEMIC DISEASES :
CHRONIC RENAL FAILURE,
TUBERCULOSIS
B) ACQUIRED HEMOLYTIC-
AUTOIMMUNE HEMOLYTIC
ANEMIA, HEMOLYTIC ANEMIA
ASS WITH MALARIA
B) CHRONIC BLOOD LOSS-
HOOKWORM INFESTATION,
HAEMORRHOIDS, PUD,
SCHISTOSOMIASIS
C) BONE MARROW
INFILTRATION :
MALIGNANCIES
5
6. CLASSIFICATION
4. BASED ON MEAN CORPUSCULAR VOLUME
6
MICROCYTIC
(MCV<80FL)
NORMOCYTIC(MCV 80-
100FL)
MACROCYTIC
(MCV>100FL)
IRON DEFICIENCY
ANEMIA
HEMORRHAGIC
ANEMIA
FOLIC ACID
DEFICIENCY
THALASSEMIAS ANEMIA OF CHRONIC
DISEASE
ANEMIA ASS WITH B12
DEFICIENCY
ANEMIA OF CHRONIC
DISEASE
AUTOIMMUNE
HEMOLYTIC ANEMIA
DRUG INDUCED
HEMOLYTIC ANEMIA
SIDEROBLASTIC
ANEMIA
ANEMIA ASS WITH
BONE MARROW
SUPPRESSION
ANEMIA ASS WITH
LIVER DISEASE
ANEMIA ASS WITH HEREDITARY
7. PATHOPHYSIOLOGY
1. PHYSIOLOGICAL ANEMIA OF PREGNANCY
• PLASMA VOLUME INCREASES BY :
- EXPANDS RAPIDLY TO UPTO 40-50% AND RED BLOOD CELL VOLUME
EXPANDS BY 20%
- BECAUSE THE EXPANSION IN PLASMA VOLUME IS HIGHER THAN
THAN THE INCREASE IN RED BLOOD CELL VOLUME, THERE IS FALL IN HB
CONCETRATION
2. INCREASE DEMAND OF IRON
• WEIGHT GAIN IN PREGNANCY
• FETUS AND THE PLACENTA
7
8. PATHOPHYSIOLOGY
3. FAULTY DIETETIC HABITS LIKE OVERCOOKING WHICH
DESTROYS NUTRITIONAL VALUE, PROBLEMS OF STORAGE
AFTER COOKING, FOOD CONSUMED THAT ARE LESS
NUTRITIOUS WHICH REDUCE IRON ABSORPTION
4. FAULTY ABSORPTION MECHANISM- BECAUSE OF HIGH
PREVALENCE OF INTESTINAL INFESTATION, THERE IS
INTESTINAL HURRY WHICH REDUCES THE IRON ABSORPTION
4. INCREASED SUSCEPTIBILITY TO MALARIA- INTERFERES WITH
ABSORPTION AND UTILIZATION OF NUTRIENTS
5. SHORT PREGNANCY INTERVAL- WOMEN START ANOTHER
PREGNANCY AT A TOO FREQUENT INTERVAL WHILE NOT GIVING
THE BODY TIME TO REPLENISH ITS DEPLETED STORES
8
9. COMMON ANEMIAS IN PREGNANCY
• COMMON TYPES- 1. NUTRIONAL DEFICIENCY ANEMIA
-IRON DEFICIENCY
- FOLATE DEFICIENCY
- VITAMIN B12 DEFICIENCY
2. HAEMOGLOBINOPATHIES
- SICKLE CELL DISEASE
- THALASSAEMIAS
10. IRON DEFICIENCY ANEMIA
• IRON DEFICIENCY CAN BE DEFINED AS ANEMIA WITH BIOCHEMICAL EVIDENCE OF
IRON DEFICIENCY BASED ON THE FOLLOWING LAB FINDINGS- SERUM FERRITIN,
SERUM IRON, TOTAL IRON BINDING CAPACITY
• ETIOLOGY- DEPLETED IRON STORES( DIETARY LACK, WORM INFESTATION,
CHRONIC MENORRHAGIA), CHRONIC INFECTIONS(MALARIA), REPEATED
PREGNANCY(SHORT INTERPREGNANCY INTERVAL, BLOOD LOSS AT DELIVERY)
• DIAGNOSIS- LAB RESULTS ARE CHARACTERISTICS OF MICROCYTIC,
HYPOCHROMIC ANEMIA WITH EVIDENCE OF DEPLETED IRON STORES, LOW
PLASMA IRON LEVELS, HIGH TIBC, LOW SERUM FERRITIN LEVELS
• IRON DEFICIENCY ANEMIA DURING PREGNANCY HAS BEEN ASS WITH INCREASED
RISK OF LOW BIRTH WEIGHT,PRETEM DELIVERY AND PERINATAL MORTALITY AND
SHOULD BE TREATED WITH IRON SUPPLEMENTATION IN ADDITION TO PRENATAL
VITAMINS
10
11. MACROCYTIC ANEMIA
• MACROCYTIC ANEMIA MAYBE MEGALOBLASTIC OR NON MEGALOBLASTIC BASED ON
THE BONE MARROW FINDINGS
• CAUSES OF MEGALOBLASTIC INCLUDE FOLATE AND VIT B12 DEFICIENCY
• MACROCYTIC ANEMIA IS CHARACTERIZED BY AN MCV GREATER THAN 100FL
• ETIOLOGY- INADEQUATE INTAKE, INCREASED DEMAND, ABNORMAL DEMAND,VIT B12
IS ENCOUNTERED IN WOMEN WHO HAD PARTIAL OR TOTAL GASTRIC RESECTION,
CROHN’S DISEASE, ,STRICT VEGETARIAN DIET
• DIAGNOSIS- LAB RESULTS ARE CHARACTERISTICS OF MACROCYTIC ANEMIA WITH
EVIDENCE OF HYPER SEGMENTED NEUTROPHILS, LOW SERUM FOLATE LEVEL, LOW
VIT B12 LEVEL
• TREATMENT- FOLIC ACID AND IRON SUPPLEMENTATION, VIT B12 GIVEN
INTRAMUSCULAR IN VIT B12 DEFICIENCY
11
12. HAEMOGLOBINOPATHIES
• SICKLE CELL ANEMIA
- SCD IS AN AUTOSOMAL INHERITED GENETIC CONDITION WHERE ABNORMAL
HB(HBS) CONTAINS BETA GLOBIN CHAINS WITH AN AMINO ACID SUBSTITUTION THAT
RESULTS IN IT PRECIPITATING WHEN IN REDUCED STATE. THE RED BLOOD CELLS
BECOME SICKLE SHAPED AND OCCLUDE SMALL BLOOD VESSELS
- THERE IS SEVERE ANEMIA, CHRONIC HYPERBILIRUBINEMIA, PREDISPOSITION TO
TO INFECTION, VASO-OCCLUSIVE COMPLICATIONS INCLUDING ACUTE CHEST
SYNDROME AND CHRONIC KIDNEY DISEASE
- DIAGNOSIS – RETICULOCYTE COUNT,SICKLING TEST, HEMOGLOBIN
ELECTROPHORESIS
- MANAGEMENT- PRE-PREGNANCY OPTIMIZATION AND EDUCATION ON RISK ON
PREGNANCY, HIGH DOSE FOLATE SUPPLEMENTS, LOW DOSE ASPIRIN, CRISES(
ADEQUATE HYDRATION, OXYGEN, ANALGESIA, SCREEN AND TREAT INFECTIONS,
BLOOD TRANSFUSION, FETAL MONITORING)
- COMPLICATIONS- MATERNAL: INCREASED RISK OF CRISES, MISCARRIAGE, PRE
12
13. HAEMOGLOBINOPATHIES
• THALASSEMIA
- COMMONEST GENETIC BLOOD DISORDERS
- THE DEFECTS IS A REDUCED PRODUCTION OF NORMAL HB AND THE SYNDROMES ARE
DIVIDED INTO ALPHA AND BETA TYPES, DEPENDING ON WHICH GLOBIN CHAIN IS AFFECTED
- IN ALPHA THALASSEMIA MINOR, THERE IS DELETION OF ONE OF THE TWO NORMAL ALPHA
GENES REQUIRED FOR HB PRODUCTION. AFFECTED INDIVIDUAL IS CHRONICALLY ANEMIC BUT
HAS LOW RISK OF OBSTETRICS COMPLICATIONS
- IN BETA THALASSEMIA, IT RESULTS FROM DEFECTS IN NORMAL PRODUCTION OF THE BETA
CHAINS. BETA THALASSEMIA MINOR IS A HETEROZYGOUS INHERITANCE FROM ONE PARENT,
PRESENTS WITH LOW MCV, LOW MCH, NORMAL MCHC AND IRON SUPPLEMENTS SHOULD BE
GIVEN AND PARTNERS SHOULD BE SCREENED
- HOWEVER IN BETA THALASSEMIA MAJOR- HOMOZYGOUS INHERITANCE FROM BOTH
PARENTS, SEVERE ANEMIA AND TREATMENT IS BLOOD TRANSFUSION
13
14. MANAGEMENT
• PRINCIPLES OF MANAGEMENT
- IDENTIFICATION OF CAUSE OF ANEMIA
•HISTORY AND CLINICAL EXAMINATION
•INVESTIGATION
-TREATMENT OF ANEMIA BY THE MOST APPROPRIATE METHOD
14
15. CLINICAL PRESENTATION
• ASYMPTOMATIC
- DETECTED ONLY ON ROUTINE ESTIMATION OF PCV OR HB AT BOOKING
•SYMPTOMATIC
- EASY FATIGABILITY, WEAKNESS, DIZZINESS, FAINTING ATTACKS, HEADACHE,
WEAKNESS, FAINTING ATTACKS, BREATHLESSNESS ,SWOLLEN LEGS, SYMPTOMS
OF PREDISPOSING CONDITION
15
16. CLINICAL EXAMINATION
• GENERAL PHYSICAL EXAMINATION
- GENERAL STATUS: POORLY OR WELL NOURISHED
-ASSESS PALLOR, JAUNDICE, HAIR FLUFFINESS, DELAYED CAPPILARY REFILL,
KOILONYCHIA, PEDAL EDEMA
. CVS EXAMS- PULSE RATE FOR TACYCARDIA, BP FOR NORMALITY; LOW(SHOCK)
OR RISE(PREECLAMPSIA), JVP MAY BE RAISED, HEART SOUNDS
. RESP SYSTEM- TACHYPNEA, CREPITATIONS AT THE LUNG BASES
. ABD EXAM- TENDER HEPATOMEGALLY
. OTHER SYSTEMS FOR ETIOLOGY AND COMPLICATIONS
16
17. INVESTIGATIONS
• TO ASCERTAIN DEGREE OF ANEMIA, TYPE OF ANEMIA, CAUSE OF ANEMIA
• HEMATOLOGICAL- FULL BLOOD COUNT, RETICULOCYTE COUNT,, BLOOD FILM
FOR MALARIA, BLOOD FILM FOR RED CELL MORPHOLOGY, HB
ELECTROPHORESIS, BLOOD GROUP AND RHESUS FACTOR, COMB
TEST(DIRECT AND INDIRECT),SERUM FOLATE, SERUM B12, IRON STUDIES, BM
ASPIRATION
• MICROBIOLOGICAL( STOOL MICROSCOPY, URINE MC/S, MANTOUX , SPUTUM
ACID FAST BACILLI
• RADIOLOGICAL- ABDOMINAL USS, CHEST XRAY
17
18. TREATMENT
• METHOD OF TREATMENT DEPENDS ON GA, SEVERITY OF ANEMIA,
SYMPTOMATOLOGY, CO-MORBIDITY, ONGOING BLOOD LOSS
• GENERAL TREATMENT
- ADEQUATE NUTRITION
- TREATMENT OF UNDERLYING CAUSE( ANTIMALARIAL, ANTIBIOTICS,
ANTIHELMENTHIC, ANTIRETROVIRAL)
. SPECIFIC TREATMENT
- HEMATINIC (ORAL AND PARENTERAL)
- BLOOD PRODUCTS
18
19. TREATMENT
• MILD ANEMIA- <37WKS ( IRON THERAPY, FOLIC ACID), AT TERM AND LABOR (
BLOOD TRANSFUSION)
• MODERATE ANEMIA- <34WKS (IRON THERAPY), >34WKS( BLOOD
TRANSFUSION)
• SEVERE ANEMIA - BLOOD TRANSFUSION IRRESPECTIVE OF GA
• ORAL IRON FORMULATION
A) FERROUS SULPHATE 200MG TDS
B) FERROUS FUMARATE 200MG
C) FERROUS GLUCONATE 300MG TDS
19
20. TREATMENT
• PARENTERAL IRON MAY BE INDICATED IF THERE IS : -
- NON COMPLIANCE WITH ORAL IRON
- MALABSORPTION SYNDROME
- INTOLERABLE SIDE EFFECTS
- SEVERE IRON DEFICIENCY
• INDICATIONS OF BLOOD TRANSFUSION:
- SEVERE ANEMIA
- CO-MORBIDITY( SEPSIS, RENAL FAILURE, HAEMORRHAGE)
- GA CLOSE TO TERM , GOING FOR SURGERY OR IN LABOR IRRESPECTIVE OF
20
21. COMPLICATIONS
• EFFECTS ON THE MOTHER- HEART FAILURE(GENERALIZED EDEMA,
TACHYCARDIA, ABNORMAL HEART SOUNDS), SHOCK, PREDISPOSITION TO PIH
AND PRETERM LABOR, REDUCED IMMUNITY TO INFECTION, INCREASED
MORTALITY RATE
• EFFECTS ON THE FETUS-ABORTION, INTRAUTERINE GROWTH RESTRICTION,
INTRAUTERINE FETAL DEATH, PREMATURITY, LOW BIRTH WEIGHT, INCREASED
RISK OF PERINATAL MORBIDITY AND MORTALITY
21
22. PREVENTION
• GOOD EDUCATION ON HOW TO IMPROVE THEIR HEALTH WELLBEING AND
IMPORTANCE OF PROPHYLACTIC HAEMATINICS AND ANTIMALARIAL
• ENCOURAGE FAMILY PLANNING
• ENCOURAGE TO COME FOR ROUTINE ANC
• DISCOURAGE HARMFUL PRACTICES LIKE FOOD TABOO
• GOOD HEALTH FACILITIES AND TRAINED PERSONNEL
22
23. CONCLUSION
• ANEMIA REMAINS A DIRECT AND INDIRECT CAUSE OF MATERNAL MORBIDITY
AND MORTALITY PARTICULARLY IN DEVELOPING COUNTRIES
• PREVENTION IS KEY TO CURTAILING THE NUMEROUS HAZARDS OF ANEMIA IN
PREGNANCY
• HEALTH EDUCATION, ADMINISTRATION OF HAEMATINICS AND ANTIMALARIAL
PROPHYLAXIS AND USE OF INSECTICIDE TREATED NETS REMAINS EFFECTIVE
IN THE PREVENTION AND MANAGEMENT OF ANEMIA
23
24. REFERENCES
• TEXTBOOK OF OBSTETRIC AND GYNAECOLOGY BY AKIN AGBOOLA
• TEXTBOOK OF OBSTETRICS BY 10 TEACHERS
• COMPREHENSIVE OBSTETRICS IN THE TROPICS
• DC DUTTA TEXTBOOK OF OBSTETRICS
24